Aeras awarded €11.7 million ($16 million) grant from Dutch ... ( Rockville/Berlin 12 November 2010 T...)

Aeras awarded €11.7 million ($16 million) grant from Dutch government

Date:11/12/2010

Rockville/Berlin, 12 November 2010 The Aeras Global TB Vaccine Foundation is pleased to announce that the Netherlands Ministry of Foreign Affairs has renewed its funding to Aeras with a pledge of an additional 11.7 million over four years (2011-2014) to further its efforts to develop new vaccines to help combat the global epidemic of tuberculosis.

This expression of support represents a continuation in the long-standing collaboration between the Dutch government, Aeras and its research partners. This is the second grant to Aeras from the Netherlands Ministry of Foreign Affairs, representing a total commitment of 30.4 million to Aeras since 2006.

"The forward movement of TB vaccine candidates in the development pipeline owes a great deal to the generous support of the Dutch Ministry of Foreign Affairs and the people of the Netherlands," said Jim Connolly, President and Chief Executive Officer of the Aeras Global TB Vaccine Foundation. "We are extraordinarily grateful for their foresight and steadfast support of these potentially life saving efforts."

TB is one of the world's deadliest infectious diseases, killing nearly 2 million men, women and children every year. Despite global efforts to prevent and treat TB, the epidemic is becoming more complex and difficult to diagnose and treat due in large part to the emergence of drug-resistant forms of TB and the emergence of the HIV epidemic. TB is responsible for the majority of AIDS deaths in Africa.

New TB vaccines are urgently needed. The currently available vaccine, Bacille Calmette-Gurin, provides some protection against pediatric TB but is unreliable in protecting adult pulmonary TB, the most common form of the disease. As a product development partnership, Aeras collaborates and facilitates research in conjunction with numerous scientists in academic, pharmaceutical, biotechnology and government research centers around the world to develop safer and more immunogenic
'/>"/>

Contact: Annmarie Leadman
aleadman@aeras.org
Aeras Global TB Vaccine Foundation
Source:Eurekalert

0

GOOD

Page: 1 2
Related biology news :

1. Aeras-led research consortium receives FDA support
2. Mississauga teacher awarded prize for excellence in teaching genomics
3. $1,820,000 from NSF awarded to Rutgers-Newark to acquire fMRI dedicated to research
4. SAIC Awarded $23 Million Task Order by Defense Biometrics Identity Management Agency
5. LSUHSC awarded $12 million for cancer, infectious diseases research & research pipeline
6. OU researchers awarded $3M DOE grant to determine effects of climate change on two ecosystems
7. Rutgers part of team awarded $3.3 million National Institutes of Health grant for prostate cancer research
8. Salk Institute Medals to be awarded to Robert Roeder and Irwin Jacobs
9. 2010 Albert Maucher Prize awarded to Potsdam palaeoclimatologist
10. Researcher awarded $2.27 million to study environmental effects on gene copy number
11. Professor Dr. Alexander (Sandy) Lawson is awarded the 2011 Herman Skolnik Award

Post Your Comments:

(Date:5/24/2013)... non-coding RNAs are small molecules that help control ... they have emerged as disease biomarkers. miRNA profiles ... cancers of unknown primary origin, determine prognosis, monitor ... tractable, diagnostic methods for monitoring miRNA expression in ... issue of the Journal of Clinical Investigation ...

(Date:5/24/2013)... 500 leading water scientists from around the world today ... the short span of one or two generations, the ... be living under the handicap of severe pressure on ... there is no substitute. This handicap will be self-inflicted ... bluntly pointed to chronic underlying problems led by mismanagement ...

(Date:5/23/2013)... Laboratory honored more than 165 staff for their ... PNNL,s annual Intellectual Property Commercialization Recognition & Rewards ... national laboratory named materials scientist Jun Liu Inventor ... materials that can store large amounts of energy, ... the time it takes to charge cell phones, ...

Breaking Biology News(10 mins):A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 2 A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 3 A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 4 PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2

[0] New fluorescent tools for cancer diagnosis [0] A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists [1] PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace

... COLUMBIA, Mo. An incurable, paralyzing disease in humans is ... Researchers from the University of Missouri and the Broad ... degenerative myelopathy (DM) in dogs is the same mutation ... also known as Lou Gehrig,s Disease. As a result ...

... insecticide used to fumigate termite-infested buildings is a strong ... times longer than previously thought, UC Irvine research has ... the atmosphere at least 30-40 years and perhaps as ... lifetime at as low as five years, grossly underestimating ...

... the University of Leicester has published research which looks into ... being exposed to. Research published today (Jan 20) ... Archives of Disease in Childhood documents the non-drug ... as part of their medical care. The study led ...

Cached Biology News:Researchers genetically link Lou Gehrig's disease in humans to dog disease 2 Termite insecticide a potent greenhouse gas 2 Research exposes the risk to infants from the chemicals used in liquid medicines 2 Research exposes the risk to infants from the chemicals used in liquid medicines 3

Researchers genetically link Lou Gehrig's disease in humans to dog disease Termite insecticide a potent greenhouse gas Research exposes the risk to infants from the chemicals used in liquid medicines

(Date:5/23/2013)... MARINO, Calif. , May 23, 2013 /PRNewswire/ ... today a strategic alliance with DAK Renewable Research ... the corn oil yield. VG Energy is a ... (OTC Pink: VGLS). VG Energy,s exclusively ... to increase the oil yield in plants, possessing ...

(Date:5/23/2013)... , May 23, 2013 Virobay, Inc. today ... pain has reached an important milestone, as Virobay has ... - a selective cathepsin S inhibitor. ... double-blind, randomized, placebo-controlled study designed to evaluate the safety, ... in healthy adults. "The initiation of this ...

(Date:5/23/2013)... (PRWEB) May 23, 2013 On April ... trips to supermarkets to search for the growing antibiotic ... aisles. Results from a year long study were released ... in foods, specifically meats, over previous years. For those ... the growth of antibiotic resistant bacteria in food, may ...

(Date:5/23/2013)... 2013 Northwest Biotherapeutics (NASDAQ: NWBO ... personalized immune therapies for solid tumor cancers, announced ... year,s American Society Of Clinical Oncology (ASCO) meeting in ... role in immune therapy. (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ... the pre-eminent conference focused on clinical treatment of cancer, ...

Breaking Biology Technology:VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2 VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3 Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2 Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3 Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2 NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2 NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3

[0] VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials [0] Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain [0] Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria [0] NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer

... Shire plc (LSE: SHP, NASDAQ: SHPGY ), the ... to September 30, 2011. Financial Highlights Q3 ... +24% Non GAAP operating income $341 million +15% US GAAP ... ADS $1.28 +10% US GAAP diluted earnings per ADS $1.02 ...

... of Colorado Boulder study shows that huge amounts of ... promote healthy heart growth, results that may have implications ... Leinwand and her research team found the amount of ... oils -- in the blood of Burmese pythons one ...

... at the Georgia Institute of Technology have developed a ... a key ingredient found in many explosives. ... on paper or paper-like material using standard inkjet technology, ... to the presence of explosives, such as improvised explosive ...

Shire plc: Continued Strong Product Sales Performance in Q3: On Track to Deliver Significant 2011 Earnings Growth CU-Boulder python study may have implications for human heart health Low-cost paper-based wireless sensor could help detect explosive devices

... new Hummingbird has the ability to quickly and ... makes it a perfect candidate for inclusion in ... OCX interface supplied with all the Cartesian products ... Hummingbirds ability to copy plates in seconds ...

Sigmas E-TOXATE (Limulus Amebocyte Lysate) test kits are intended for the detection and semiquantitation of endotoxins for research purposes. sensitivity 0.05-0.1 EU/mL...

... isolation chamber provides a safe, clean ... pharmaceuticals, in accord with USP-797 requirements. ... (ISO 5) cleanliness conditions in the ... rod and tilt-up front panel for ...

... Protein determined by Biuret. Physical ... (NH 4 ) 2 SO ... Note: Affinity purified • Physical ... Additives: MgCl 2 1 ...

Biology Products:

Hummingbird for Compound Library Management from Genomic Solutions Endotoxin Gel formation Assay Kit, E-TOXATE from Sigma-Aldrich Pharmaceutical Compounding Chamber from Terra Universal, Inc.Bovine Phosphatase, Alkaline bovine intestinal mucosa, Unconjugated from Sigma-Aldrich